Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus Effect in Thrombocytopenia Treatment
IRCT20210715051904N2Phase 3Completed
- Sponsor
- Bushehr University of Medical Sciences
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sirolimus in immune thrombocytopenia (ITP) and Thrombocytopenia (2 arms), sponsored by Bushehr University of Medical Sciences. Started Jul 2025; status: completed.
02
Drugs
sirolimus
03
Conditions
immune thrombocytopenia (ITP)Thrombocytopenia
Beyond the preview
Go deeper on IRCT20210715051904N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210715051904N2.